As previously mentioned, after treatment with Rb1, through activation of the PI3K/Akt/Nrf2 signaling pathway, serum or tissue level of SOD were increased in spinal cord injury and intestinal ischemia/reperfusion model rats (30–32). The gene discussed is AKT1; the disease is ischemia.